B2TN01 AF NFT

D-aminoacyl-tRNA deacylase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicmfv7pp2btolivmzazu36x7dc4ms3lqxzleuk2xbqw5uvgmapewe/metadata.json
IPFS of structure file: 
bafybeihekpjzt3lqr7g6czhbbds2tehzh2rhbswqkdi6deswigc42h7oeq/AF-B2TN01-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xf15ee9678a76Fa6d624D70b80730d9238AFAaBa2
First NFT owner address (bech32): 
genesis1790wjeu2wmax6cjdwzuqwvxeyw9042az5d023r
Current NFT ID #106163 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
106163
Accession (UniProt):
B2TN01
Name::
D-aminoacyl-tRNA deacylase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Eklund 17B / Type B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2TN01 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2TN01|DTD_CLOBB D-aminoacyl-tRNA deacylase OS=Clostridium botulinum (strain Eklund 17B / Type B) OX=935198 GN=dtd PE=3 SV=1 MRAVVQRVTSSSVQVDGNIVGSIGRGLNVLIGISKSDTLQDLKYIRDKVINLRIFEDEKDKMNLSILDVKGELLVISQFTLYGDCRKGRRPNFMEAKGGEEAEGLYKEFLSLLKESNIKIETGEFGADMKVEINNDGPVTIILDSSKNF